GAD2 and type 1 diabetes mellitus: Importantly, the authors assessed differences in response to GABA and GAD65 Alum treatment from patients with T1D-associated HLA-DR3-DQ2 and HLA-DR4-DQ8 haplotypes (both HLA class II).